What is SHARe?
A 14-member consortium launched by the CCTS to build on the strengths of our Partner Network to develop a truly transformational research enterprise in multisite studies for the Deep South.
Who is in SHARe?
Auburn University, HudsonAlpha Institute for Biotechnology, Louisiana State University Health Sciences Center, Ochsner Health System, Our Lady of the Lake Regional Medical Center, Pennington Biomedical Research Center, Southern Research, Tulane University, Tuskegee University, University of Alabama, University of Alabama at Birmingham, University of Mississippi, University of Mississippi Medical Center, and University of South Alabama.
Why Use SHARe?
- Multisite studies and clinical trials require a high degree of coordination among study sites. SHARe reduces the redundancies and eases the administrative burdens that slow typical time-to-activation. CCTS SHARe members sign on to a master IRB reliance agreement, streamlining the review process.
- Multisite studies and clinical trials frequently struggle with recruitment. SHARe offers access to a large, regional, and varied patient population. Whether you are studying a rare or chronic disease, looking for a genetic anomaly, or testing the effects of an intervention or treatment by gender, age, race/ethnicity, socioeconomic status, or geographic location, the SHARe network increases the odds of quickly building a robust list of potential participants who meet your research criteria.
- Multisite studies and clinical trials that participate in SHARe will help spur trans-network innovation among faculty, physicians, and other health care providers, resulting in discoveries that can rapidly improve health care and, ultimately, benefit communities across the region.
How Do I Propose a Study to SHARe?
Principal investigators from across any SHARe institution who are interested in proposing a study should contact the SHARe Program Manager,
SHARe Trials Initiated
In our first year, SHARe facilitated eight studies--a sample of these are listed below.
| STUDY TITLE | PARTICIPATING SHARe SITES (*lead site) | ||
| Olanzapine for CINV in Patients Undergoing Multi-Day, High Dose Chemotherapy Prior to SCT |
Ochsner, Tulane, UAB*, UMMC | ||
| Antihypertensives for Mild Chronic Hypertension during Pregnancy: A Pragmatic Multicenter Randomized Trial |
Ochsner, Tulane, UAB*, UMMC Arkansas - CTSA |
||
| Do Health Disparities in the Deep South Impact Neonatal Palliative Care?: Parents Perspectives |
Children’s Hospital New Orleans, LSU Children's Hospital, UAB* Batson Children's Hospital, UMMC |
||
| Pembrolizumab in HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms |
LSU*, UAB | ||
| Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) |
Ochsner (Baton Rouge & New Orleans), UAB* | ||
| A Phase II Study of Cabozantinib for Recurrent or Persistent Cervical Cancer |
USA* UAB, Tulane |
SHARe Advisory Committee
The SHARe Advisory Committee provides oversight for the group’s activities, including evaluating the merit of proposed studies, facilitating participation, and resolving administrative issues. Each institution appoints its own members. The SHARe Advisory Committee meets by phone on the second Thursday of every month from 12:00-12:30 pm CT. Interested in participating? Contact a SHARe Committee member at your institution or